Platinum derivatives during pregnancy in cervical cancer: A systematic review and meta-analysis

Obstetrics and Gynecology

Volumn 121, Issue 2 PART 1, 2013, Pages 337-343

  Zagouri, Flora ^a,b   Sergentanis, Theodoros N ^a,b   Chrysikos, Dimosthenis ^a,b   Bartsch, Rupert ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; VINCRISTINE;

ADULT; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL EFFECTIVENESS; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; MONOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREGNANCY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CERVICAL NEOPLASMS;

EID: 84873818376     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31827c5822     Document Type: Review

References (40)

1. NCCN Clinical Practice Guidelines in Oncology. Cervical cancer. Version 1. 2012. Available at: www.nccn.com. Retrieved September 1, 2012.
2. Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N; ESMO Guidelines Working Group. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v266-73.
3. Haie-Meder C, Morice P, Castiglione M; ESMO Guidelines Working Group. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v37-40.
4. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
5. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
6. Long HJ 3rd, Bundy BN, Grendys EC Jr, Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005;23:4626-33.
7. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009;27:4649-55.
8. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004;22:3113-9.
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34.
10. Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F. Use of platinum derivatives during pregnancy. Cancer 2008;113:3069-74.
11. Fruscio R, Villa A, Chiari S, Vergani P, Ceppi L, Dell'Orto F, et al. Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review. Gynecol Oncol 2012;126:192-7.
12. Li J, Wang LJ, Zhang BZ, Peng YP, Lin ZQ. Neoadjuvant chemotherapy with paclitaxel plus platinum for invasive cervical cancer in pregnancy: two case report and literature review. Arch Gynecol Obstet 2011;284:779-83.
13. da Fonseca AJ, Dalla-Benetta AC, Ferreira LP, Martins CR, Lins CD. Neoadjuvant chemotherapy followed by radical surgery in pregnant patient with invasive cervical cancer: case report and literature review [in Portuguese]. Rev Bras Ginecol Obstet 2011;33:43-8.
14. Lanowska M, Köhler C, Oppelt P, Schmittel A, Gottschalk E, Hasenbein K, et al. Addressing concerns about cisplatin application during pregnancy. J Perinat Med 2011;39:279-85.
15. Marnitz S, Köhler C, Oppelt P, Schmittel A, Favero G, Hasenbein K, et al. Cisplatin application in pregnancy: first in vivo analysis of 7 patients. Oncology 2010;79:72-7.
16. Rabaiotti E, Sigismondi C, Montoli S, Mangili G, Candiani M, Viganò R. Management of locally advanced cervical cancer in pregnancy: a case report. Tumori 2010;96:623-6.
17. Chun KC, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn J Clin Oncol 2010;40:694-8.
18. Favero G, Lanowska M, Schneider A, Marnitz S, Köhler C. Laparoscopic pelvic lymphadenectomy in a patient with cervical cancer stage Ib1 complicated by a twin pregnancy. J Minim Invasive Gynecol 2010;17:118-20.
19. Marnitz S, Schmittel A, Bolbrinker J, Schmidt FP, Fons G, Kalache K, et al. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum. Fertil Steril 2009;92:1748.e1-4.
20. Boyd A, Cowie V, Gourley C. The use of cisplatin to treat advanced-stage cervical cancer during pregnancy allows fetal development and prevents cancer progression: report of a case and review of the literature. Int J Gynecol Cancer 2009;19:273-6.
21. Palaia I, Pernice M, Graziano M, Bellati F, Panici PB. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol 2007;197:e5-6.
22. Karam A, Feldman N, Holschneider CH. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol 2007;4:375-80.
23. Bader AA, Petru E, Winter R. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Gynecol Oncol 2007;105:269-72.
24. Benhaim Y, Pautier P, Bensaid C, Lhommé C, Haie-Meder C, Morice P. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Eur J Obstet Gynecol Reprod Biol 2008; 136:267-8.
25. Caluwaerts S, VAN Calsteren K, Mertens L, Lagae L, Moerman P, Hanssens M, et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer 2006;16:905-8.
26. Marana HR, de Andrade JM, da Silva Mathes AC, Duarte G, da Cunha SP, Bighetti S. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol 2001;80:272-4.
27. Giacalone PL, Laffargue F, Benos P, Rousseau O, Hedon B. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol 1996;103:932-4.
28. Lai CH, Hsueh S, Chang TC, Tseng CJ, Huang KG, Chou HH, et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 1997;64:456-62.
29. Tewari K, Cappuccini F, Gambino A, Kohler MF, Pecorelli S, DiSaia PJ. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 1998;82:1529-34.
30. Seamon LG, Downey GO, Harrison CR, Doss B, Carlson JW. Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy. Gynecol Oncol 2009;114:540-1.
31. Gambino A, Gorio A, Carrara L, Agoni L, Franzini R, Lupi GP, et al. Cancer in pregnancy: maternal and fetal implications on decision-making. Eur J Gynaecol Oncol 2011;32:40-5.
32. Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal followup after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 2010;33:221-8.
33. Abellar RG, Pepperell JR, Greco D, Gundogan F, Kostadinov S, Schwartz J, et al. Effects of chemotherapy during pregnancy on the placenta. Pediatr Dev Pathol 2009;12: 35-41.
34. Favero G, Chiantera V, Oleszczuk A, Gallotta V, Hertel H, Herrmann J, et al. Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecol Oncol 2010;118:123-7.
35. Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, et al. Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci 1989;14:115-30.
36. Levine BS, Preache MM, Pergament E. Mutagenic potential of cis-dichlorodiammine platinum II in rodents. Toxicology 1980; 17:57-65.
37. Köpf-Maier P. Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment. Eur J Cancer Clin Oncol 1983;19:533-6.
38. Jones WB, Shingleton HM, Russell A, Fremgen AM, Clive RE, Winchester DP, et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 1996;77:1479-88.
39. Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV Jr, Zaino R, et al. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol 2006;103:541-6.
40. Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R. Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology 2012;83:234-8.